PD-L1-positive non-small cell lung cancerivonescimabCR-001
…28(3):111722.Xiong, et al. Ivonescimab versus pembrolizimab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomized, double-blind, phase 3 study in China…
Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…28(3):111722.Xiong, et al. Ivonescimab versus pembrolizimab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomized, double-blind, phase 3 study in China…